Reply to T. J. A. Dekker, D.-C. Mo et al, and A. Seidman et al

Cristina Saura¹, Mafalda Oliveira¹, Sung-Bae Kim¹+3

• ¹Cristina Saura, MD, PhD and Mafalda Oliveira, MD, PhD, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), SOLTI Breast Cancer Cooperative Group, Barcelona, Spain; Sung-Bae Kim, MD, PhD, University of Ulsan College of Medicine, Seoul, Republic of Korea; Thomas Yau, MD, MBBS, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, China, Toshimi Takano, MD, Toranomon Hospital, Tokyo, Japan; and Adam Brufsky, MD, PhD, Magee-Womens Hospital of UPMC, Pittsburgh, PA.